Wallace C Duncan Jr
Overview
Explore the profile of Wallace C Duncan Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kheirkhah M, Duncan Jr W, Yuan Q, Wang P, Jamalabadi H, Leistritz L, et al.
Neuropsychopharmacology
. 2025 Feb;
PMID: 39955416
Abnormalities during rapid eye movement (REM) sleep contribute to the pathophysiology of major depressive disorder (MDD), but few studies have explored the relationship between REM sleep and treatment-resistant depression (TRD)....
2.
Ballard E, Greenstein D, Reiss P, Crainiceanu C, Cui E, Duncan Jr W, et al.
Transl Psychiatry
. 2024 Jun;
14(1):238.
PMID: 38834540
The glutamatergic modulator ketamine is associated with changes in sleep, depression, and suicidal ideation (SI). This study sought to evaluate differences in arousal-related sleep metrics between 36 individuals with treatment-resistant...
3.
Hejazi N, Duncan Jr W, Kheirkhah M, Kowalczyk A, Riedner B, Oppenheimer M, et al.
J Psychiatr Res
. 2024 May;
174:332-339.
PMID: 38697012
Electroencephalographic (EEG) deficits in slow wave activity or Delta power (0.5-4 Hz) indicate disturbed sleep homeostasis and are hallmarks of depression. Sleep homeostasis is linked to restorative sleep and potential...
4.
Punturieri C, Duncan Jr W, Greenstein D, Shandler G, Zarate Jr C, Evans J
Int J Methods Psychiatr Res
. 2023 Sep;
:e1984.
PMID: 37668277
Objectives: This study explored the potential of non-parametric and complexity analysis metrics to detect changes in activity post-ketamine and their association with depressive symptomatology. Methods: Individuals with treatment-resistant depression (TRD:...
5.
Ballard E, Greenstein D, Duncan Jr W, Hejazi N, Gerner J, Zarate Jr C
Biol Psychiatry Glob Open Sci
. 2022 May;
2(1):36-44.
PMID: 35492205
Background: Nocturnal wakefulness has emerged as a potential predictor of short-term suicide risk. This analysis used dynamic temporal patterns in alpha and beta power and global sleep metrics to explore...
6.
Hejazi N, Farmer C, Oppenheimer M, Falodun T, Park L, Duncan Jr W, et al.
J Psychiatr Res
. 2022 Jan;
148:27-33.
PMID: 35092868
The Hamilton Depression Rating Scale (HDRS), which includes several insomnia-related items, is potentially valuable in evaluating both depressive and sleep symptoms. However, the HDRS insomnia items have not been fully...
7.
Smith A, Morse R, Introne W, Duncan Jr W
Am J Med Genet A
. 2019 Jan;
179(2):224-236.
PMID: 30690916
Smith-Magenis syndrome (SMS) is a contiguous gene syndrome linked to interstitial microdeletion, or mutation of RAI1, within chromosome 17p11.2. Key behavioral features of SMS include intellectual disability, sleep-disturbances, maladaptive, aggressive...
8.
Duncan Jr W, Slonena E, Hejazi N, Brutsche N, Park L, Henter I, et al.
Neuropsychiatr Dis Treat
. 2018 Nov;
14:2739-2748.
PMID: 30410340
Purpose: This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine....
9.
Duncan Jr W, Ballard E, Zarate C
Handb Exp Pharmacol
. 2017 Sep;
253:337-358.
PMID: 28939975
Ketamine, a drug with rapid antidepressant effects and well-described effects on slow wave sleep (SWS), is a useful intervention for investigating sleep-wake mechanisms involved in novel therapeutics. The drug rapidly...
10.
Duncan Jr W, Slonena E, Hejazi N, Brutsche N, Yu K, Park L, et al.
Biol Psychiatry
. 2017 May;
82(5):361-369.
PMID: 28457485
Background: The rapid clinical antidepressant effects of the glutamatergic modulator ketamine may be due to its ability to restore synaptic plasticity and related effects on sleep-wake and circadian systems. Preclinical...